Latest Campaign Updates

80,000 people have signed the AllTrials petition

80,000 people have signed the AllTrials petition! The first 80,000 putting their shoulders to the wheel have:

Swayed a vote in Europe
Helped make registration an ethical requirement in the UK
Made a regulator reverse restrictions on sharing data
Amended law in Canada
Convinced some pharma companies to start sharing trial data
Started building the campaign in Spain & Latin […]

16th September 2014|

Respond to EMA and FDA consultations by Monday

We urgently need you to respond to two important consultations to defend independent analyses.
Tell the EMA not to censor independent analyses
In Europe, the medicines regulator wants the right to censor analyses of side effects data that it disagrees with. The European Medicines Agency (EMA) is consulting on updates to its EudraVigilance access policy. EudraVigilance is […]

11th September 2014|

New EU president moves regulation of medicines to industry department

New EU president Juncker has taken the responsibility for the regulation of medicines away from the health department and handed it to the industry department. This means that the section of the European Commission with oversight for the European Medicines Agency (EMA) will no longer be DG SANCO (the Health and Consumers Directorate General) and will now be […]

11th September 2014|

MPs told that there’s a “moral imperative” for all trial results to be published

The Chair of NICE has told MPs on the House of Commons Health Select Committee that when clinical trial results are kept hidden, the contribution of patients gets ignored. NICE, the National Institute for Health and Care Excellence, is the UK public body which evaluates the benefits and cost effectiveness of medicines and treatments […]

5th September 2014|

Open University joins AllTrials

Professor Tim Blackman, Pro-Vice Chancellor Research, Scholarship and Quality, The Open University:
The Open University is pleased to support the AllTrials campaign’s call for full and open reporting of medical trials. As a provider of science and health education and open educational resources accessed by thousands of people worldwide, the Open University is committed to […]

2nd September 2014|

Faculty of Pharmaceutical Medicine surveys members about trial transparency

The Faculty of Pharmaceutical Medicine (FPM) has released a survey of its members’ attitudes about clinical trial transparency. 379 people completed the 24 question survey from the 23rd September to 28th October 2013. Members completing the survey were asked to “respond as pharmaceutical physicians with a duty and responsibility to patients, research subjects and […]

2nd September 2014|

Oxford University Hospitals commits to AllTrials

Oxford University Hospitals NHS Trust has pledged its support for increased transparency in medical research by supporting the AllTrials campaign.
Oxford University Hospitals has signed the campaign pledge and commits to the principles that all clinical trials should be registered and the results should be published.
The Trust supports a growing portfolio of more than 1,300 […]

22nd August 2014|

AllTrials writes to the members of the EMA Management Board

The EU medicines body has been discussing the final wording of its draft policy on sharing data from clinical trials. We and hundreds of you have been urging them not to take a backwards step on transparency. The Management Board of the European Medicines Agency (EMA) sets policies for the EMA and delayed agreeing […]

19th August 2014|

Barriers to clinical trials in India

In an article on The New Indian Express, members of the Indian Society for Clinical Research (ISCR) say that recent regulations are to blame for a drop in the number of clinical trials being conducted in India. The Indian government introduced new regulations following a Supreme Court ruling in 2013, one of which requires […]

18th August 2014|

Most discontinued trials remain unpublished

A new research paper in JAMA looking at 1017 clinical trials has found that most trials stopped before the planned end remain unpublished, and overall 56% never published results. An international research group was given access to the records of all the clinical trials approved by six ethics committees in Switzerland, Germany and Canada […]

14th August 2014|